1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 07 MARCH 2016

Cancer Drug News 07 MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Unlocking High-Potential Reservoirs Will Drive Exponential Cancer Revenue Growth
Industry Brief - FDA Approves New Indication For Faslodex
Industry Brief - Poziotinib Phase II Trial Initiated In Advanced BC
Industry Brief - Onconova Receives Rigosertib Deal Termination Notice From Baxalta
Industry Brief - Amgen Submits Blincyto sBLA To FDA
Industry Brief - EMA Grants ODD To Venetoclax In AML; Recommends Giotrif In Advance SCC
Industry Trend Analysis - AstraZeneca Faces Challenges In Navigating Transitional Period
Industry Brief - Eusa/Aveo Seek EU Marketing Approval For Tivozanib In Advanced RCC
Industry Brief - Combination Trial Of Avelumab/VS-6063 Initiated In Ovarian Cancer
Industry Brief - Debiopharm Sees Victory In Japanese Oxaliplatin Lawsuit
Industry Brief - Ono Gains Japanese Approval For Partial Change In Opdivo Labelling
Industry Brief - Yondelis Approved for Sale In Six Additional Countries
Industry Brief - Merck Enters Oncology Research Collaboration With EMBL
Industry Brief - Exelixis/Ipsen Enter Cabozantinib Licensing Deal
Industry Brief - Eisai's Halaven Approved In Japan To Treat STS
Industry Trend Analysis - Precision Medicine Development Driven By Big Data
Industry Trend Analysis - Baxalta Building Immuno-Oncology Capabilities
Industry Brief - Specialized Therapeutics/Mundipharma Enter Sublicensing Deal For Anti-Emetic Products

Table Of Contents

Cancer Drug News 07 MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.